Among the companies with shares expected to actively trade in Tuesday's session are Elizabeth Arden Inc. (RDEN), Vertex Pharmaceuticals Inc. (VRTX), Walgreen Co. (WAG) and xG Technology Inc. (XGTI).

Elizabeth Arden unveiled details of a cost-savings plan that will include job cuts, supply-chain reorganization and closing its Puerto Rico affiliate, among other things. Shares fell 7.4% to $26.20 premarket.

Vertex said that an experimental treatment combined with its Kalydeco drug significantly improved lung function for a certain type of cystic fibrosis in a pair of Phase 3 studies. Shares jumped 51% to $100.43 in premarket trading.

Shares of Walgreen fell 1.3% to $72.75 premarket as its top and bottom lines grew less than expected and the company pulled its goals for fiscal year 2016, saying key decisions still need to be made about its Alliance Boots partnership.

xG Technology said the U.S. Army chose it as a subcontractor on a $497 million communications and networking contract. Shares rose 68% to $3.10.

 
   Watchlist: 
 

Abbott Laboratories (ABT) agreed to acquire Russian drug maker Veropharm for up to $495 million, a deal that give the U.S. pharmaceutical company a manufacturing presence in that country. The deal marks the biggest U.S. deal for a Russian firm since the Ukraine crisis spiraled out of control this year.

Avon Products Inc. (AVP) plans to cut an additional 600 jobs, largely in its corporate staff and North America business, as part of the beauty-products company's ongoing turnaround efforts.

Blackstone Group LP (BX) set plans to pare its stake in Hilton Worldwide Holdings Inc. (HLT) by about $2 billion, following the end of the lockup period for the hotelier's initial public offering.

Dean Foods Co. (DF) recently received a subpoena from criminal authorities ordering the company to produce information for an insider-trading investigation of activist investor Carl Icahn, pro golfer Phil Mickelson and sports bettor William T. Walters, The Wall Street Journal reported, citing a person familiar with the matter.

Forest Laboratories Inc. (FRX) reported positive top-line results from three Phase 3 trials of vilazodone in adult patients with generalized anxiety disorder.

Micron Technology Inc.'s (MU) profit surged in its fiscal third quarter, buoyed by the company's acquisition of Elpida Memory Inc. and signs of stability in one of tech's most turbulent markets.

Refiner Tesoro Corp. (TSO) outlined plans to shift some terminal and pipeline properties to its limited partnership. Tesoro Logistics LP (TLLP) plans to acquire three marketing terminals, a storage facility and a refined-products pipeline for about $270 million, with $243 million expected to be in cash and the remainder in equity.

Write to Maria Armental at maria.armental@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Abbott Laboratories Charts.